Oncoinvent ASA (KLDVK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oncoinvent ASA (KLDVK) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr3.64 Million ≈ $383.35K USD) by net assets (Nkr277.49 Million ≈ $29.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KLDVK company net worth for the company's overall valuation and market capitalisation.
Oncoinvent ASA - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Oncoinvent ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Oncoinvent ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oncoinvent ASA ranked by their cash flow conversion efficiency. Explore KLDVK operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZUARI INDUSTRIES LIMITED
NSE:ZUARIIND
|
0.003x |
|
Samil Pharm
KO:000520
|
0.016x |
|
Micropolis Holding Company
NYSE MKT:MCRP
|
0.063x |
|
Globe International Ltd
AU:GLB
|
0.097x |
|
Antalpha Platform Holding Co
NASDAQ:ANTA
|
-0.018x |
|
Barington/Hilco Acquisition
NASDAQ:BHAC
|
-0.004x |
|
DHI Group Inc
NYSE:DHX
|
0.049x |
|
Pylon Public Company Limited
BK:PYLON
|
0.022x |
Annual Cash Flow Conversion Efficiency for Oncoinvent ASA (2021–2025)
The table below shows the annual cash flow conversion efficiency of Oncoinvent ASA from 2021 to 2025. View KLDVK stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr277.49 Million ≈ $29.20 Million |
Nkr-23.24 Million ≈ $-2.45 Million |
-0.084x | -51.09% |
| 2024-12-31 | Nkr267.76 Million ≈ $28.18 Million |
Nkr-14.84 Million ≈ $-1.56 Million |
-0.055x | +60.91% |
| 2023-12-31 | Nkr283.70 Million ≈ $29.85 Million |
Nkr-40.23 Million ≈ $-4.23 Million |
-0.142x | -7399.20% |
| 2022-12-31 | Nkr192.02 Million ≈ $20.21 Million |
Nkr373.06K ≈ $39.26K |
0.002x | +66.94% |
| 2021-12-31 | Nkr112.27 Million ≈ $11.81 Million |
Nkr130.66K ≈ $13.75K |
0.001x | -- |
About Oncoinvent ASA
Kaldvik AS engages in the salmon farming business in Iceland. It also operates smolt stations. The company was incorporated in 2020 and is headquartered in Eskifjörður, Iceland. Kaldvik AS was formerly known as Ice Fish Farm AS and changed its name to Kaldvik AS in August 2024. Kaldvik AS operates as a subsidiary of Austur Holding As.